Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues    
Total revenues $ 43,706 $ 11,313
Cost of sales    
Total cost of sales 45,034 11,900
Gross profit/(loss) (1,328) (587)
Operating expenses    
Research and development 24,605 10,858
Sales and marketing 19,689 5,449
General and administrative 23,857 13,846
Total operating expenses 68,151 30,153
Loss from operations (69,479) (30,740)
Change in fair value of warrant liability   (56,576)
Interest expense 32 (73)
Interest and other (expense) income, net (1,753) 361
Loss before income taxes (71,200) (87,028)
Income tax benefit 1,256 27,920
Net loss $ (69,944) $ (59,108)
Net loss per share-Basic $ (0.22) $ (0.25)
Net loss per share-Diluted $ (0.22) $ (0.25)
Weighted average shares outstanding basic 312,016,627 238,243,779
Weighted average shares outstanding diluted 312,016,627 238,243,779
Products    
Revenues    
Total revenues $ 39,476 $ 10,311
Cost of sales    
Total cost of sales 41,902 10,487
Services    
Revenues    
Total revenues 4,230 1,002
Cost of sales    
Total cost of sales $ 3,132 $ 1,413